Xeris (XERS) Chief Legal Officer Beth Hecht Sells 16,666 Shares

What Happened
Beth Hecht, Chief Legal Officer and Corporate Secretary of Xeris Biopharma Holdings (XERS), reported an open-market sale of 16,666 shares on 2026-09-01. The shares were disposed for a total of approximately $141,434; the filing lists a weighted-average price of $8.49 per share (individual trades ranged from $8.39 to $8.60).

Key Details

• Transaction type: Sale (S) — open market or private sale
• Transaction date: 2026-09-01; filing date: 2026-09-01 (timely)
• Shares sold: 16,666; weighted-average price: $8.49; total value ≈ $141,434
• Price range: $8.39 to $8.60 across multiple trades (report states weighted average)
• Plan/authorization: Sold pursuant to a Rule 10b5-1 trading plan adopted August 8, 2025 (footnote)
• Shares owned after transaction: Not disclosed in the provided filing
• Additional note: The reporting person offers to provide a breakdown of number of shares sold at each price on request

Context
This was a planned sale under a pre-established 10b5-1 trading plan, which typically allows insiders to sell shares according to a preset schedule regardless of short-term company news. Sales are common insider activity and do not, by themselves, indicate management’s view of long-term prospects.